Clinical Trial Update: Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the combination of venetoclax and vincristine in adults with relapsed or refractory B- or T-cell acute lymphoblastic leukemia and lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-lymphoblastic Lymphoma
• T-cell Acute Lymphoblastic Leukemia
• T-lymphoblastic Lymphoma

Drugs mentioned

• Venetoclax (venetoclax)
• Vincristine (vincristine)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-25